Valuation: Sanofi

Capitalization 93.53B 111B 85.32B 81.33B 151B 10,066B 157B 991B 394B 4,846B 416B 407B 17,016B P/E ratio 2025
12.9x
P/E ratio 2026 * 11.9x
Enterprise value 106B 125B 96.48B 91.98B 171B 11,384B 177B 1,121B 446B 5,480B 470B 461B 19,243B EV / Sales 2025
2.56x
EV / Sales 2026 * 2.23x
Free-Float
87.31%
Yield 2025
4.98%
Yield 2026 * 5.46%
1 day-0.32%
1 week-3.72%
Current month-2.31%
1 month-5.22%
3 months-13.64%
6 months-8.92%
Current year-6.47%
1 week 77.34
Extreme 77.34
82.95
1 month 76.83
Extreme 76.83
82.95
Current year 76.83
Extreme 76.83
84.97
1 year 76.15
Extreme 76.15
110.88
3 years 76.15
Extreme 76.15
110.88
5 years 74.92
Extreme 74.92
110.88
10 years 62.5
Extreme 62.5
110.88
Manager TitleAgeSince
Chief Executive Officer 58 01/09/2019
Director of Finance/CFO 63 01/04/2024
Chief Operating Officer 41 01/10/2023
Director TitleAgeSince
Director/Board Member 72 01/05/2014
Director/Board Member 60 30/04/2019
Director/Board Member 58 30/10/2019
Name Varia. Jan 1. Weight AuM
+2.78%3.66% 158 M€
Change 5d. change 1-year change 3-years change Capi.($)
-0.32%-3.72%-25.39%-12.71% 111B
+0.17%-1.72%+23.18%+210.44% 929B
-0.45%+1.44%+55.91%+52.76% 587B
+1.76%+3.61%+20.03%+53.25% 409B
+0.39%+1.40%+22.72%+30.42% 374B
+0.28%+7.49%+29.48%+31.05% 320B
+1.05%+5.42%+32.60%+56.70% 311B
+1.82%-0.43%+46.26%+12.75% 301B
-0.95%+4.11%-44.82%-37.79% 219B
+0.82%-3.94%+26.80%+53.79% 199B
Average +0.31%+1.32%+18.68%+45.07% 376.01B
Weighted average by Cap. +0.31%+1.22%+25.85%+77.66%

Financials

2025 2026 *
Net sales 43.51B 51.58B 39.69B 37.84B 70.3B 4,683B 72.94B 461B 183B 2,255B 193B 189B 7,917B 46.38B 54.98B 42.31B 40.34B 74.94B 4,992B 77.75B 492B 195B 2,403B 206B 202B 8,439B
Net income 8.14B 9.65B 7.43B 7.08B 13.16B 876B 13.65B 86.31B 34.31B 422B 36.2B 35.46B 1,482B 8.38B 9.94B 7.65B 7.29B 13.54B 902B 14.05B 88.86B 35.32B 434B 37.27B 36.5B 1,525B
Net Debt 12.24B 14.51B 11.17B 10.64B 19.78B 1,317B 20.52B 130B 51.57B 634B 54.42B 53.3B 2,227B 9.79B 11.61B 8.93B 8.52B 15.82B 1,054B 16.42B 104B 41.26B 507B 43.54B 42.65B 1,782B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (79.8%): prescription drugs in the areas of specialty medicine (63.2% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (36.8%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (20.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2024, the group had 52 production sites worldwide. In October 2024, the consumer healthcare products business (Opella) was classified as a discontinued operation. Net sales are distributed geographically as follows: France (4.4%), Europe (17.6%), the United States (48.7%), China (6.5%) and other (22.8%).
Employees
82,878
Date Price Change Volume
16/02/26 77.37 -0.32% 1,668,547
13/02/26 77.62 -1.87% 3,788,057
12/02/26 79.10 -4.19% 5,965,759
11/02/26 82.56 +0.44% 2,018,884
10/02/26 82.20 +2.38% 2,483,671
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
77.62EUR
Average target price
98.70EUR
Spread / Average Target
+27.16%

Quarterly revenue - Rate of surprise